Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
3
×
texas blog main
texas top stories
wisconsin blog main
3
×
wisconsin top stories
alnylam pharmaceuticals
biotech
celgene
deals
drug prices
sanofi
2019
abiraterone
ac immune
acorda therapeutics
activism
acute hepatic porphyria
aduro biotech
agenus
What
bio
drug
3
×
gene
3
×
roundup
prices
therapy
advanced
alnylam’s
alzheimer’s
approval
aren’t
bff
companies
conference
deals
developers
devoted
different
disease
drugs
easl
fail
fda
form
help
imminent
increases
kicked
latest
liver
long
major
medicare
moves
news
noteworthy
patients
pharmaceutical
plan
prescription
Language
Current search:
drug
×
" wisconsin blog main "
×
gene
×
" seattle top stories "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
6 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More